Secondary prevention of early-onset sepsis: a less invasive Italian approach for managing neonates at risk
- PMID: 29954420
- PMCID: PMC6025713
- DOI: 10.1186/s13052-018-0515-8
Secondary prevention of early-onset sepsis: a less invasive Italian approach for managing neonates at risk
Abstract
Strategies to prevent early-onset sepsis (EOS) have led to a substantial decline in many countries. However, one of the most controversial topics in neonatology is the management of asymptomatic full-term and late preterm neonates at risk for EOS, and guidelines lack substantial consensus regarding this issue. A strategy for managing neonates, entirely based on serial physical examinations, has been developed in two Italian regions. This strategy seems safe, while reducing laboratory tests and unnecessary antibiotics. In the current commentary we provide area-based data concerning the prevention of EOS in 2 northern Italian regions, and we detail the results of their strategy for managing healthy-appearing newborns at risk for EOS.
Keywords: Group B streptococcus; Intrapartum antibiotic prophylaxis; Neonatal sepsis; Newborn infant; Prevention; Risk factors.
Conflict of interest statement
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Dr. Alberto Berardi has received funding from the Agenzia Sanitaria Regione dell’Emilia-Romagna: “Assegnazione e concessione di finanziamenti alle Aziende Sanitarie Regionali per la realizzazione di programmi di interesse regionale a sostegno del Piano Regionale della Prevenzione 2015-2018 C.U.P. n. E43G17000680002”.
The remaining authors declare they have no funding source.
Financial disclosure: Dr. Alberto Berardi has received fees from these Companies: Pfizer.
(2015), Putnam Associates (2016) and GSK (2017).
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Comment on
-
Strategies for preventing group B streptococcal infections in newborns: a nation-wide survey of Italian policies.Ital J Pediatr. 2017 Nov 2;43(1):98. doi: 10.1186/s13052-017-0409-1. Ital J Pediatr. 2017. PMID: 29096709 Free PMC article.
References
-
- Verani JR, McGee L, Schrag SJ. Division of bacterial diseases, National Center for Immunization and Respiratory Diseases, Centres for disease control and prevention (CDC). Prevention of perinatal group B streptococcal disease — revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010;59(RR-10):1–36. - PubMed
-
- Tzialla C, Berardi A, Farina C, Clerici P, Borghesi A, Viora E, et al. Task force for group B streptococcal infections for the Italian Society of Neonatology; Italian Society of Obstetricians and Gynecologists; Italian Association of Clinical Microbiologists. Strategies for preventing group B streptococcal infections in newborns: a nation-wide survey of Italian policies. Ital J Pediatr. 2017;43:98. doi: 10.1186/s13052-017-0409-1. - DOI - PMC - PubMed
-
- Cantoni L, Ronfani L, Da Riol R, Demarini S. Physical examination instead of laboratory tests for most infants born to mothers colonized with group B Streptococcus: support for the Centers for Disease Control and Prevention’s 2010 recommendations. J Pediatr. 2013;163:568–573. doi: 10.1016/j.jpeds.2013.01.034. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical